Erratum: Hsu CA, Rishi AK, Su-Li X, et al. Retinoid induced apoptosis in leukemia cells through a retinoic acid nuclear receptor-independent pathway. Blood. 1997;89(12):4470-4479. (Blood (2021) 137(22) (3027–3036), (S0006497121006959), (10.1182/blood.V89.12.4470));Retinoid induced apoptosis in leukemia cells through a retinoic acid nuclear receptor-independent pathway

Blood

Volumn 89, Issue 12, 1997, Pages 4470-4479

  Hsu, C Alex ^b   Rishi, Arun K ^b   Su Li, Xiao ^a   Gerald, Tonya M ^b   Dawson, Marcia I ^b   Schiffer, Charles ^b   Reichert, Uwe ^b   Shroot, Braham ^b   Poirer, Guy C ^b   Fontana, Joseph A ^a  

^a Bressler Research Laboratories 11 019   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

RETINOIC ACID RECEPTOR; RETINOID;

ACUTE MYELOBLASTIC LEUKEMIA; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DEATH; CELL PROLIFERATION; DNA DEGRADATION; DNA SEQUENCE; DRUG INDUCED DISEASE; ENZYME INHIBITION; GROWTH INHIBITION; LEUKEMIA CELL; NONHUMAN; POLYCLONAL ACTIVATION; PRIORITY JOURNAL; TRANSACTIVATION;

EID: 0031008522     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood.2022017469     Document Type: Erratum

References (71)

1. Sporn MB, Roberts AB: Interaction of retinoids and transforming growth factor-B in the regulation of cell differentiation and proliferation. Mol Endocrinology 5:37, 1991
2. Moon RC, Itri LM: Retinoids and Cancer, in Sporn MB, Roberts AB, Goodman DS (eds): The Retinoids, vol 2. New York, NY, Academic, 1980, p 327
3. Lotan R: Effects of vitamin A and its analogs (retinoids) on normal and neoplastic cells. Biochem Biophys Acta 605:33, 1980
4. Breitman TR, Selonick SE, Collins SJ: Induction of differentiation of the human promeylocytic leukemia cell line (HL-60) by retinoic acid. Proc Natl Acad Sci USA 77:2936, 1980
5. Fontana JA: Interaction of retinoids and tanoxifen in the inhibition of human mammory carcinoma cell proliferation. Exp Cell Biol 55:136, 1987
6. Van der Burg B, Van der Leede BJM, Kwakkenbos Isbrucker L, Salverda S, de Laat SW, Van der Saag PT: Retinoic acid resistance of estradiol-independent breast cancer cells coincides with diminished retinoic acid receptor function. Mol Cell Endocrinol 91:149, 1993
7. Roman SD, Ormandy CJ, Manning DL, Blamey RW, Nicholson RI, Sutherland RL, Clarke CL: Estradiol induction of retinoic acid receptors in human breast cancer cells. Cancer Res 53:5970, 1993
8. Shiekh MS, Shao Z-M, Chen JC, Hussain, A, Jetten AM, Fontana JA: Estrogen receptor-negative breast cancer cells transfected with the estrogen receptor exhibit increased RARα gene expression and sensitivity to growth inhibition by retinoic acid. J Cell Biochem 53:394, 1993
9. Giguere V: Retinoic acid receptors and cellular retinoid binding proteins: Complex interplay in retinoid signalling. Endocrine Rev 15:61, 1994
10. Gudas L: Retinoids and vertebrae development. J Biol Chem 269:15399, 1994
11. Mangelsdorf DJ, Evans RM: The RXR heterodimers and orphan receptors. Cell 83:841, 1995
12. Schule R, Rangarajan P, Yang N, Kliewer S, Ransone LJ, Bolado J, Verma IM, Evans RM: Retinoic acid is a negative regulator of AP-1 responsive genes. Proc Natl Acad Sci USA 88:6092, 1991
13. Kamei Y, Xu L, Heinzel T, Torchia J, Kurokawa R, Gloss B, Lin S-C, Heyman RA, Rose DW, Glass CK, Rosenfeld MG: A CBP Integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 85:403, 1996
14. 1 arrest and apoptosis induced by a novel retinoid in human breast cancer cells. Oncogene 11:493, 1995
15. Bernard BA, Bernardon JM, Delesclose C, Martin B, Lenoir, MC, Maignan J, Charpentier B, Pilgrim WR, Reichert U, Shroot B: Identification of synthetic retinoids with selectivity for human nuclear retinoic acid receptor γ. Biochem Biophys Res Commun 186:977, 1992
16. Robertson KA, Emami B, Collins, SJ,: Retinoic acid resistant HL-60R cells harbor a point mutation in the retinoic acid receptor ligand-binding domain that confers dominant negative activity. Blood 80:1881, 1992
17. Nagy L, Thomazy VA, Shipley GL, Fesus L, Lamph W, Heyman RA, Chandraratina RAS, Davies PJA: Acitvation of retinoid X receptors induces apoptosis in HL-60 cell lines. Mol Cell Biol 15:3570, 1995
18. Kaufmann SH, Desnoyers S, Ottavino Y, Davidson NE, Poirer GG: Specific proteolytic cleavage of poly (ADP-ribose) polymerase: An early marker of chemotherapy-induced apoptosis. Cancer Res 53:3976, 1993
19. Charpentier B, Bernardon JM, Eustache J, Millois C, Martin B, Michel S, Shroot B: Syntheisis, structure affinity relationships and biological activities of ligands binding to retinoic acid receptor subtyes. J Med Chem 38:4993, 1995
20. El-Diery WS, Tokino T, Vielculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler, KW, Vogelstein B: WAF1 a potential mediator of p53 tumor suppression. Cell 75:817, 1993
21. Zhan Q, Bae I, Kastan MB, Fornace AJ Jr: The p53 dependent γ ray response of GADD45. Cancer Res 54:2755, 1994
22. Laborda J: 36B4 cDNA used as an estradiol-independent mRNA control is the cDNA for human acidic ribosomal phosphoprotein. Nucleic Acids Res 19:3998, 1991
23. Feinberg AP, Vogelstein B: A technique for radiolabelling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 132:6, 1983
24. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid quanidinium thiocyanate-phenol chloroform extraction. Anal Biochem 162:156, 1987
25. Li X-S, Chen JC, Sheikh MS, Shao ZM, Fontana JA: Retinoic acid inhibition of insulin-like growth factor I stimulation of C-Fos mRNA levels in a breast carcinoma cell line. Exp Cell Res 211:68, 1994
26. Sheikh MS, Li X-S, Chen JC, Shao ZM, Ordonez JV, Fontana JA: Mechanism of regulation of WAF1/Cip1 gene expression in human breast carcinoma. Role of p53-dependent and independent signal transduction pathways. Oncogene 9:3407, 1994
27. Whitacre CM, Hashimato, H, Tsai, ML Chatterjee S, Berger SJ, Berger NA: Involvement of NAD poly (ADP-ribose) metabolism in p53 regulation and its consequences. Cancer Res 55:3697, 1995
28. Robertson KA, Mueller J, Collins SJ: Retinoic acid receptors in myeloid leukemia. Characterization of receptors in retinoic acid-resistant K-562 cells. Blood 77:340, 1991
29. Issacs JT: Advances and controversies in the study of programmed cell death/apoptosis in the development of and therapy for cancer. Curr Opin Oncol 6:82, 1994
30. Yuan J, Shaham S, Ledoux S, Ellis HM, Horvitz HR: The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1β-converting enzyme. Cell 75:641, 1993
31. Kuman S, Kinoshita M, Noda M, Copeland NG, Jenkins NA: Induction of apoptosis by the mouse Nedd 2 gene which encodes a protein similar to the product of the Caenor habditis elegans cell death gene ced-3 and the mammalian IL-1β-converting enzyme. Genes Dev 8:1613, 1994
32. Wang L, Miura M, Bergerson L, Zhu H, Yuan J: Ich-1 an Ice/ced-3 related gene encodes both positive and negative regulators of programmed cell death. Cell 78:739, 1994
33. Faucheu C, Diu A, Chan AWE, Blanchet AM, Miossec C, Herve F, Collard-Dutilloul V, Guy Y, Aldape RA, Lippke JA, Rocher C, Su MS-S, Livingston DJ, Hercend T, Lalanne JL: A novel human protease similar to the interleukin-1β converting enzyme induces apoptosis in transfected cells. EMBO J 14:1917, 1995
34. Kamens J, Paskind M, Huguinin M, Talanian RV, Allen H, Banach D, Bump N, Hackett M, Johnston CG, Li P, Mankouitch JA, Terranova M, Ghayur T: Identification and characterization of Ich-2, a novel member of the interleukin-1β converting enzyme family of cysteine proteases. J Biol Chem 270:15250, 1995
35. Munday NA, Vaillancort JP, Ali A, Casano FJ, Miller DK, Molineau SM, Yamin TT, Yu VL, Nicholson DW: Molecular cloning and pro-apoptotic activity of ICE rel-II and ICE rel III, members of the ICE/CED-3 family of cysteine proteases. J Bio Chem 270:15250, 1995
36. Fernandes-Alnermiri T, Litwack G, Alnemri ES: Mch 2a new member of the apoptotic Ced-3/ICE cysteine protease gene family. Cancer Res 55:2737, 1995
37. Vaux DL, Strasser A: The molecular biology of apoptosis. Proc Natl Acad Sci USA 93:2239, 1996
38. Lazebnik YA, Kaufman SH, Desnoyers S, Poirier GG, Earnshaw WC: Cleavage of poly (ADP-ribose)polymerase by a proteinase with properties like ICE. Nature 371:346, 1994
39. Neamati N, Fernandez A, Wright S, Kiefer J, McConkey DJ: Degradation of lamin B1 precedes oligonucleosomal DNA fragmentation in apoptotic thymocytes and isolated thymocyte nuclei. J Immunol 154:1693, 1994
40. Nicholson DW, Ali A, Thornberry NA, Vaillancort JJP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle M, Lazebnik YA, Munday NA, Raju SM, Smulson ME, Yamin TT, Yu VL, Miller DK: Identification and inhibition of the ICE/ced-3 protease necessary for mammalian apoptosis. Nature 376:37, 1995
41. Oberhammer FA, Hochegger K, Froschi G, Tiefenbacher R, Pauelka M: Chromatin condensation during apoptosis is accompanied by degradation of lamin A + B without enhanced activation of cdc2 kinase. J Cell Biol 126:827, 1994
42. Tewari M, Quan LT, O'Rourke K, Desnoyers S, Zeng Z, Beidler DR, Poirer GG, Salvesen GS, Dixit VM: Yama/CPP32 B. A mammalian homolog of CED-3 is a CRM A-inhibitable protease that cleaves the death substrate poly (ADP-Ribose) polymerase. Cell 81:801, 1995
43. Han Z, Chatterjee D, Early J, Pantazis P, Herdrickson EA, Wyche JH: Isolation and characterization of an apoptosis-resistant variant of human leukemia HL-60 cells that has switched expression from bcl-2 to bcl-XL. Cancer Res 56:1621, 1996
44. Haldar S, Jena H, Croce CM: Inactivation of bcl-2 by phosphorylation. Proc Natl Acad Sci USA 92:4507, 1995
45. 1 arrest and apoptosis. Cancer Res 54:1169, 1994
46. 1 cyclin-dependent kinases. Cell 75:805, 1993
47. Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D: P21 is a universal inhibitor of cyclin kinases. Nature 366:701, 1993
48. Macleod KF, Sherry N, Hannon G, Beach D, Torino T, Kinzler K, Vogelstein B, Jacks T: p53-dependent and independent expression of p21 during cell growth differentiation and DNA damage. Genes Dev 9:935, 1995
49. Kastan MB, Radin AI, Kuergitz SJ, Onyekwere O, Walkow CA, Civin CI, Stone KD, Woo T, Ravindravath Y, Craig RW: Levels of p53 protein increase with maturation in human hematopoietic cells. Cancer Res 51:4279, 1991
50. cip1. Oncogene 11:1675, 1995
51. Zhan Q, Lord KA, Alano I Jr, Hallander MC, Carrier R, Ron D, Kohn KW, Hoffman B, Liebermann DA, Fornace AJ Jr: The gadd and MyD genes define a novel set of mammalian genes encoding acidic proteins that synergistically suppress cell growth. Mol Cell Biol 14:2361, 1994
52. Chomienne C, Ballerini P, Balitrand N, Daniel MT, Fenaux P, Castaigne S, Degos L: All-trans retinoic acid in acute promyelocytic leukemias II. In vitro studies: Structure-function relationship. Blood 76:1710, 1990
53. Huang ME, Chen Y, Shu-rong C, Jin-ren C, Jia-Xiang L, Long-Jun G, Zhen-yi W: Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 72:567, 1988
54. Castaigne S, Chomienne C, Daniel MT, Ballerini P, Berger R, Fenaux P, Degos L: All trans-retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical Results. Blood 76:1707, 1990
55. Kakizuka A, Miller WH, Umesono K, Warrell RP Jr, Frankel SR, Murty VVVS, Dimitrovsky E, Evans RM: Chromosomal translocation t(15:17) in human acute promeylocytic leukemia fuses RARα with a novel putative transcription factor, PML. Cell 66:663, 1991
56. deThe H, Lavau C, Marchio A, Chomienne C, Degos L, Dejean A: The PML-RARα fusion mRNA generated by the t(15:17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell 66:675, 1991
57. Weis K, Rambaud S, Levau C, Jansend J, Carvalho T, Carmo-Fonseca M, Lamond A, Dejean A: Retinoic acid regulates aberrant nuclear localization of PML-RARα in acute promyelocytic leukemia cells. Cell 76:345, 1994
58. Dyck JA, Maul GG, Miller WH Jr, Chen D, Kakizuka A, Evans RM: A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein. Cell 76:333, 1994
59. Doucas V, Brockes JP, Yaniv M, deThe H, DeJean A: The PML-retinoic acid receptor α translocation converts the receptor from an inhibitor to a retinoic acid dependent activator of transcription factor AP-1. Proc Natl Acad Sci USA 90:9345, 1993
60. Smith MA, Parkinson DR, Cheson BD, Friedman MA: Retinoids in cancer therapy. J Clin Oncol 10:7839, 1992
61. Degos L, Dombert H, Chomienne C, Daniek MT, Miclea JM, Chastang C: All trans-retinoic acid as a differentiating agent in the treatment of acute promyelocytic leukemia. Blood 85:2673, 1995
62. Steinman RA, Hoffman B, Iro A, Guillouf Lieberman DA, EL-Houseini ME: Induction of p21 (WAF1 -CIP1) during differentiation. Oncogene 9:3389, 1994
63. Robertson KA, Emami B, Mueller L, Collins SJ: Multiple members of the retinoic acid receptor family are capable of mediating granulocytic differentiation of HL-60 cells. Mol Cell Biol 12:3473, 1992
64. waf1/cip1 expression in human breast carcinoma cells. Cancer Res 56:5055, 1996
65. Akaski M, Hachiya M, Osawa Y, Spirin K, Suzudi G, Koeffler HP: Irradiation induces WAF1 expression through a p53-independent pathway in KG-1 cells. J Biol Chem 270:19181, 1995
66. 1 checkpoint control. Cell 82:675, 1995
67. waf1/cip1 induces growth arrest, giant cell formation and apoptosis in human breast carcinoma cell lines. Oncogene 11:1899, 1995
68. Caducei D, Wersto R, Cowan KH, Seth P: Effects of a recombinant adenovirus expressing WAF1/CIP1 on cell growth, cell cycle and apoptosis. Cell Growth Diff 6:1207, 1995
69. cip1. Oncogene 11:1675, 1995
70. Zhan Q, Lord KA, Alamo I Jr, Hollander MC, Carrier R, Ron D, Kohn, KW, Hoffman B, Lieberman DA, Fornace AJ Jr: The gadd and MyD genes define a novel set of mammalian genes encoding acidic proteins that synergistically suppress cell growth. Mol Cell Biol 4:2361, 1994
71. Mayer RJ, Davis RB, Schiffer CA, Bery DT, Powell BL, Schulman P, Frei E III: Comparative evaluation of intensive post-remission therapy with different dose schedules of Ara C in adults with acute myeloid leukemia (AML). Initial results of a CALGB phase III study. Proc Am Soc Clin Oncol 11:261, 1992